SCM
ABBV icon

Saxony Capital Management’s AbbVie ABBV Stock Holding History

Saxony Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$639K Sell
2,538
-70
-3% -$15.1K 0.29% 76
2026
Q1 		$567K Buy
2,608
+141
+6% +$31.3K 0.33% 75
2025
Q4 		$564K Buy
2,467
+1
+0% +$228 0.35% 70
2025
Q3 		$571K Sell
2,466
-1
-0% -$204 0.38% 60
2025
Q2 		$458K Buy
2,467
+226
+10% +$42K 0.35% 62
2025
Q1 		$470K Buy
2,241
+101
+5% +$19.6K 0.41% 54
2024
Q4 		$380K Buy
2,140
+436
+26% +$80.2K 0.33% 68
2024
Q3 		$336K Sell
1,704
-692
-29% -$129K 0.31% 84
2024
Q2 		$411K Sell
2,396
-1
-0% -$166 0.45% 61
2024
Q1 		$437K Sell
2,397
-52
-2% -$8.96K 0.53% 50
2023
Q4 		$380K Buy
+2,449
New +$357K 0.5% 53

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Saxony Capital Management's ABBV Position: Q2 2026 in Review

Saxony Capital Management reduced its AbbVie (ABBV) stake by 2.7% in Q2 2026, selling an estimated $15.1K and leaving 2,538 shares worth $639K. The position accounts for 0.29% of the portfolio, ranked #76.

Saxony Capital Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Saxony Capital Management held 2,538 shares of AbbVie worth $639K as of Q2 2026.
  • Saxony Capital Management sold 70 AbbVie shares in Q2 2026, an estimated $15.1K.
  • AbbVie made up 0.29% of Saxony Capital Management's portfolio in Q2 2026, its #76 holding.
  • Saxony Capital Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Saxony Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.